Sepsis & infection

Low apolipoprotein A-II levels causally contribute to increased mortality in septic shock

J Intensive CarePublished Cohort study with genetic association and Mendelian randomization analysis

Main finding · Septic shock mortality with low apolipoprotein A-II levels (Japan cohort)Result — go to the resultAdjusted odds ratio 1.05 95% CI 1.02–1.09

Authors' conclusion

In septic shock, apolipoprotein A-II levels and ApoA2 genetic variations are important factors associated with outcome.

Study context

Population
Japanese patients with septic shock at ICU admission; Caucasian replication cohort (VASST)Japan cohort
Participants
687 patients
Exposure
Low vs higher apolipoprotein A-II levels; ApoA2 rs6413453 GG vs AG/AA carriers
Outcome
In-hospital mortality (association with lipoprotein and apolipoprotein levels at ICU admission)
Methodological detailsreplication cohort, genome-wide association study (GWAS)-based polygenic scores
  • Replication cohort
  • GWAS-based polygenic scores

Main finding

As reported in the abstract

Septic shock mortality with low apolipoprotein A-II levels (Japan cohort)

Adjusted odds ratio

1.05

95% CI 1.02–1.09

P < 0.001

Low apolipoprotein A-II
aOR 1.05 (95% CI 1.02–1.09); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)P value
28-day mortality, rs6413453 GG vs AG/AA (Japan cohort)1.79 (1.06–3.04)P = 0.029
28-day mortality, GG vs AG/AA (Caucasian VASST replication cohort) · replication cohort, n = 4741.65 (1.02–2.68)P = 0.041
OutcomeOR (95% CI)P value
Mortality per 1 mg/dL genetically decreased apolipoprotein A-II (Mendelian randomization, 9 SNPs)CI as printed1.05 (1.01–1.03)P = 0.0022

Days free of cardiovascular, respiratory, renal and neurologic dysfunction, GG vs AG/AA

Significantly fewer days free of organ dysfunction in GG carriers

Original publication

Low apolipoprotein A-II levels causally contribute to increased mortality in septic shock. J Intensive Care. Published 20 February 2025. doi:10.1186/s40560-025-00782-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.